China
Africa
Explore chapters and articles related to this topic
Nutritional Optic Neuropathy
Published in Vivek Lal, A Clinical Approach to Neuro-Ophthalmic Disorders, 2023
William Sultan, Giulia Amore, Uchenna Francis Nwako, Stacey Aquino Cohitmingao, Samuel Asanad, Alfredo Sadun
Recovery of visual function may take several weeks to months although residual permanent damage to the optic nerve may sometimes persist. Ophthalmologic examinations should be performed to quantify improvement of the visual function every 3–4 weeks and then every 6 months. Visual acuity and color vision should be assessed at each visit and bilateral visual field and OCT examinations should be performed regularly.
Oculocutaneous albinism
Published in Electra Nicolaidou, Clio Dessinioti, Andreas D. Katsambas, Hypopigmentation, 2019
Mira Kadurina, Anastasiya A. Chokoeva, Torello Lotti
Further follow-up is also mandatory in order to assess the potential residual pigmentation that can increase with time, mostly through pheomelanin.5 Comparison with other family members may be also a helpful diagnostic tool. Ophthalmologic examination is also essential for the correct diagnosis.12 As a number of vision-related problems are often associated with albinism, a detailed eye examination may be needed. The ophthalmologist will assess the baby for nystagmus, strabismus, and photophobia. Electrodiagnostic testing in which small electrodes are placed on the scalp to test the connection of the brain and eyes is also sometimes conducted.12
Launching Other Leaders: Publishing, Speaking, and Advocacy
Published in Mindi K. McKenna, Perry A. Pugno, William H. Frist, Physicians as Leaders, 2018
Mindi K. McKenna, Perry A. Pugno, William H. Frist
To help other physicians become leaders requires an investment of time, energy, and sometimes financial expenditure to support their development. Certainly, one way of doing this involves personal investment in relationships with the physicians we work with directly. “When teaching, it is important to ensure your audience gets the message. Effective presenters don’t just show fancy graphics; good speakers make sure their points are clearly conveyed. I even teach courses to help people improve their presentation skills.”Daniel S. Durrie, md Ophthalmologist President Durrie Vision Center
The paediatric optometry alignment program – a model of interprofessional collaborative eyecare
Published in Clinical and Experimental Optometry, 2023
Ann L Webber, Lynne McKinlay, Dana Newcomb, Shuan Dai, Glen A Gole
Scalable interprofessional collaborative (IPC) approaches, which enable primary health care professionals to practice to their full scope, can improve patient access to limited specialist services, particularly for those in rural and remote regions. In the Australian eyecare context, ophthalmology-optometry IPCs have developed frameworks for adult eye disorders including glaucoma, diabetic retinopathy, and macular degeneration.3–11 These models adopt a tiered approach, with optometrists delivering primary care focused on assessment of vision, management of refractive errors through issuing spectacles and screening for ocular disease, provision of routine follow-up for stable eye disease, and referral to ophthalmology for care that is outside their scope of practice. Ophthalmologists focus on provision of secondary and tertiary care, including diagnosis, medical and surgical management of serious ocular disease. This approach aims to reduce low value care, such as provision of primary care by the scarce ophthalmology workforce, and to maximise patient safety through facilitating timely access to the most appropriate level of eyecare professional.
Accuracy of the International Classification of Diseases, 9th Revision for Identifying Infantile Eye Disease
Published in Ophthalmic Epidemiology, 2022
Timothy T. Xu, Cole E. Bothun, Tina M. Hendricks, Sasha A. Mansukhani, Erick D. Bothun, Launia J. White, Brian G. Mohney
Using the Rochester Epidemiology Project, an extensive diagnostic code search utilizing 1,007 eye-related ICD-9 codes was performed to identify all potential patients diagnosed with any ocular disease in the first year of life during the 10-year study period (Supplemental eTable). Patients were excluded if they lived outside Olmsted County at the time of diagnosis, if their birth date was outside the study period, or if they were older than 12 months when diagnosed with an ocular condition. All medical records identified via the ICD-9 diagnostic code search were individually reviewed to assess diagnoses and demographic data. For provider specialty, eye specialists were defined as ophthalmologists and optometrists. Non-eye specialists were defined as all other specialties including pediatrics, family medicine, and emergency medicine.
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
Published in Ocular Immunology and Inflammation, 2022
Tomona Hiyama, Yosuke Harada, Yoshiaki Kiuchi
For adult patients, an initial dose of 80 mg ADA was administered subcutaneously; this was followed by 40 mg subcutaneously at 2-week intervals, which began 1 week after the initial dose. For pediatric patients, 40 mg ADA was administered at 2-week intervals without a loading dose, in accordance with the recommended dose for treatment of juvenile idiopathic arthritis-associated uveitis.26 Prior to the administration of ADA, an extensive work-up was performed, including chest radiography, cardiologic examination, exclusion of tuberculosis and syphilis, hepatitis B and C serology, complete blood count, and hepatic and renal function tests. Permission was granted by the Evaluation Committee on Unapproved or Off-labeled Drugs with High Medical Needs at Hiroshima University for unapproved usage (e.g., ADA for patients with severe anterior uveitis or pediatric patients with non-juvenile idiopathic arthritis Non-infectious uveitis, and MTX for patients with Non-infectious uveitis). While CyA administered prior to ADA was discontinued when ADA was initiated, MTX was continued during ADA therapy. All patients were examined by several ophthalmologists at each visit, at intervals of ≤2 months, depending on their clinical courses. Best-corrected visual acuity, tonometry, optical coherence tomography, and full-slit-lamp examination were performed at each visit. When necessary, laser flare photometry, fluorescein angiography, and/or indocyanine green angiography were performed. Laboratory tests were performed regularly during ADA treatment.